Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER

Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
Naoki Ishiguro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Nozawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Tsujihata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asami Saito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wataru Kishimoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazutoshi Yokoyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takafumi Yotsumoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Sakai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Igarashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikumi Tamai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We investigated influx and efflux transporters involved in blood-brain barrier transport of the nonsedative H1-antagonist epinastine. The basal-to-apical transport of [14C]epinastine was markedly higher than that in the opposite direction in LLC-GA5-COL150 cells stably transfected with human multidrug resistance (MDR)1 gene. The brain-to-plasma concentration ratio of [14C]epinastine in mdr1a/b(-/-) mice was 3.2 times higher than that in wild-type mice. The uptake of both [3H]mepyramine and [14C]epinastine into immortalized rat brain capillary endothelial cells (RBEC)1 showed temperature and concentration dependence. The kinetic parameters, Km, Vmax, and uptake clearance (Vmax/Km), of the initial uptake of [3H]mepyramine and [14C]epinastine by RBEC1 were 150 μM, 41.8 nmol/min/mg protein, and 279 μl/min/mg protein for mepyramine and 10.0 mM, 339 nmol/min/mg protein, and 33.9 μl/min/mg protein for epinastine, respectively. The uptake of [3H]mepyramine and [14C]epinastine by RBEC1 was inhibited by organic cations such as quinidine, amantadine, and verapamil, but not by other organic cations, tetraethyl ammonium, guanidine, and carnitine. Organic anions such as benzoic acid, estrone-3-sulfate, taurocholate, and neutral digoxin were not inhibitory. Furthermore, some cationic H1 antagonists (chlorpheniramine, cyproheptadine, ketotifen, and desloratadine) inhibited the [3H]mepyramine and [14C]epinastine uptake into RBEC1. In conclusion, the present study demonstrated that the combination of efficient efflux transport by P-glycoprotein and poor uptake by the influx transporter, which is identical with that responsible for the uptake of mepyramine, account for the low brain distribution of epinastine.

Footnotes

  • ↵1 Abbreviations used are: CNS, central nervous system; AUC, area under the curve; BBB, blood-brain barrier; BCEC, brain capillary endothelial cell; LY335979, (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzo suber-5-yl]-2-hydroxypropoxy}-quinilone trihydrochloride; MCT, monocarboxylic acid transporter; MDR, multi-drug resistance; MRP, multidrug resistance-associated protein; OAT, organic anion transporter; OATP, organic anion-transporting polypeptide; (r)OCT, (rat) organic cation transporter; OCTN, novel organic cation transporter; P-gp, P-glycoprotein; RBEC, rat brain capillary endothelial cells; TEA, tetraethyl ammonium.

    • Received September 8, 2003.
    • Accepted February 12, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (5)
Drug Metabolism and Disposition
Vol. 32, Issue 5
1 May 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER

Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
Drug Metabolism and Disposition May 1, 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER

Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
Drug Metabolism and Disposition May 1, 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
  • Biodistribution of Lipid in Rats
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics